ProfileGDS4132 / 213394_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 88% 89% 89% 86% 84% 86% 86% 86% 86% 84% 76% 84% 86% 79% 82% 75% 83% 77% 80% 73% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101367.43388
GSM201543Muscle PCOS pioglitazone 121371.80989
GSM201544Muscle PCOS pioglitazone 161437.66989
GSM201545Muscle PCOS pioglitazone 201378.51386
GSM201829Muscle PCOS pioglitazone 231326.03584
GSM201830Muscle PCOS pioglitazon 251346.75386
GSM201831Muscle PCOS pioglitazone 271353.56786
GSM201832Muscle PCOS pioglitazone 31338.48486
GSM201833Muscle PCOS pioglitazone 41335.10486
GSM201834Muscle PCOS pioglitazone 81331.54684
GSM201835Muscle PCOS after pioglitazone 102243.70876
GSM201836Muscle PCOS after pioglitazone 122321.05484
GSM201837Muscle PCOS after pioglitazone 162337.62386
GSM201838Muscle PCOS after pioglitazone 202280.36179
GSM201839Muscle PCOS after pioglitazone 232306.13682
GSM201840Muscle PCOS after pioglitazone 252249.31775
GSM201841Muscle PCOS after pioglitazone 272303.60383
GSM201842Muscle PCOS after pioglitazone 32226.50377
GSM201843Muscle PCOS after pioglitazone 42276.64380
GSM201844Muscle PCOS after pioglitazone 82234.27373